OKLAHOMA CITY, OKLAHOMA – INSURICA added to its capabilities with the Jan. 1 acquisition of Atlanta-based C&S Specialty Underwriters.
C&S Specialty Underwriters, a Managing General Underwriter (MGU) that specializes in underwriting commercial general, professional, pollution and excess liability for construction, environmental and other specialty risks in the excess and surplus lines market is poised for exponential growth.
“I’m excited. INSURICA is an excellent fit culturally and strategically”,” C&S President Preston Starr said. “We will continue to focus on organic growth with our existing broker and carrier partners. We will also find opportunities to acquire underwriting talent in other industry verticals. Our goal is to dig in and utilize the resources at INSURICA to help build out a data and technology platform to enhance our underwriting and create scale.”
C&S Specialty Underwriters will continue to be led by Starr and the same group of talented, experienced underwriters.
With this addition, INSURICA creates the in-house ability to craft exclusive industry-focused programs.
“Our new partnership with C&S is a watershed moment for our company,” INSURICA CEO Mike Ross said. “The addition of C&S Specialty Underwriters, with their experience and expertise in program business, further secures INSURICA’s place among America’s elite brokerages.”
Placing over $1 billion in annual premiums for our clients, INSURICA is among the 50 largest insurance brokers in the United States and is currently the 42nd largest privately-held independent agency in the country.
Headquartered in Oklahoma City, INSURICA employs more than 700 colleagues in 35+ offices located throughout 11 states.
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.